Detalles de la búsqueda
1.
Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study.
Hematol Oncol
; 42(1): e3228, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731313
2.
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study.
Br J Haematol
; 200(6): 802-811, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36470677
3.
[Resolution of dasatinib-associated lymphadenopathy following discontinuation of dasatinib in patients with chronic myeloid leukemia].
Rinsho Ketsueki
; 63(7): 725-732, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-35922939
4.
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
Ann Hematol
; 99(12): 2787-2800, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32879992
5.
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.
Am J Hematol
; 99(2): E55-E59, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165064
6.
A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
Haematologica
; 103(6): 1018-1028, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29242302
7.
Efficacy and safety of a 5-day regimen of azacitidine for patients with high-risk myelodysplastic syndromes.
Eur J Haematol
; 97(3): 228-31, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26613362
8.
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.
Int J Clin Oncol
; 21(5): 996-1003, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27017611
9.
Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia.
Blood
; 121(16): 3095-102, 2013 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-23412094
10.
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.
Hematol Oncol
; 33(1): 9-14, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24519501
11.
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy].
Rinsho Ketsueki
; 56(4): 392-9, 2015 Apr.
Artículo
en Japonés
| MEDLINE | ID: mdl-25971269
12.
European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.
Cancer Sci
; 105(1): 105-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24450386
13.
Peripheral blood absolute lymphocyte/monocyte ratio as a useful prognostic factor in diffuse large B-cell lymphoma in the rituximab era.
Eur J Haematol
; 92(3): 204-10, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24283206
14.
Validation of the European Group for Blood and Marrow Transplantation (EBMT) risk score in patients receiving allogeneic hematopoietic stem cell transplantation at a single center in Japan.
Clin Transplant
; 28(4): 403-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24655161
15.
Pretransplantation Inflammatory and Nutritional Status in Elderly Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Value of C-Reactive Protein-to-Albumin Ratio.
Transplant Cell Ther
; 30(4): 400.e1-400.e9, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253183
16.
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
Int J Hematol
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795248
17.
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Int J Hematol
; 119(2): 164-172, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233702
18.
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol
; 119(1): 24-38, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38015362
19.
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).
Int J Hematol
; 119(2): 130-145, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091231
20.
MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.
Cancer Sci
; 104(12): 1670-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24112697